참고문헌
- Amsellem V, Kryszke MH, Hervy M, et al (2005). The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells. Exp Cell Res, 304, 443-56. https://doi.org/10.1016/j.yexcr.2004.10.035
- Bao Y-P, Yi Y, Peng L-L, et al (2013). Roles of microRNA-206 in osteosarcoma pathogenesis and progression. Asian Pac J Cancer Prev, 14, 3751-5. https://doi.org/10.7314/APJCP.2013.14.6.3751
- Benjamini Y (2010). Discovering the false discovery rate. J R Stat Soc Series B Stat Methodol, 72, 405-16. https://doi.org/10.1111/j.1467-9868.2010.00746.x
- Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol, 289-300.
- Breitkreutz BJ, Stark C, Tyers M (2003a). The GRID: The general repository for interaction datasets. Genome Biol, 4, R23. https://doi.org/10.1186/gb-2003-4-3-r23
- Breitkreutz BJ, Stark C, Tyers M (2003b). Osprey: a network visualization system. Genome Biol, 4, R22. https://doi.org/10.1186/gb-2003-4-3-r22
- Cuomo M E, Knebel A, Platt G, et al (2005). Regulation of microfilament organization by Kaposi sarcoma-associated herpes virus-cyclin.CDK6 phosphorylation of caldesmon. J Biol Chem, 280, 35844-58. https://doi.org/10.1074/jbc.M503877200
- Densmore C L, Kleinerman ES, Gautam A, et al (2001). Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes. Cancer Gene Therapy, 8, 619-27. https://doi.org/10.1038/sj.cgt.7700343
- Di Cristofano C, Leopizzi M, Miraglia A, et al (2010). Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell. Mod Pathol, 23, 1012-20. https://doi.org/10.1038/modpathol.2010.77
- Duncan D, Prodduturi N, Zhang B (2010). WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. Bmc Bioinformatics, 11, P10. https://doi.org/10.1186/1471-2105-11-S4-P10
- Emmrich S, Katsman-Kuipers J, Henke K, et al (2013). miR- 9 is a tumor suppressor in pediatric AML with t (8; 21). Leukemia, ????????
- Fan WD, Zhang XQ, Guo HL, et al (2012). Bioinformatics analysis reveals connection of squamous cell carcinoma and adenocarcinoma of the lung. Asian Pac J Cancer Prev, 13, 1477-82. https://doi.org/10.7314/APJCP.2012.13.4.1477
- Ferrari S, Smeland S, Mercuri M, et al (2005). Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol, 23, 8845-52. https://doi.org/10.1200/JCO.2004.00.5785
- Hoffman A E, Liu R, Fu A, et al (2013). Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis. Cancer Epidemiol Biomarkers Prev, 22, 327-36. https://doi.org/10.1158/1055-9965.EPI-12-1131-T
- Hu S, Xu C, Guan W, et al (2013). Texture feature extraction based on wavelet transform and gray-level co-occurrence matrices applied to osteosarcoma diagnosis. Biomed Mater Eng, 23, S129-S43.
- Huang da W, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44-57. https://doi.org/10.1038/nprot.2008.211
- Huang G, Nishimoto K, Zhou Z, et al (2012). miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res, 72, 908-16. https://doi.org/10.1158/0008-5472.CAN-11-1460
- Hwang W, Cho YR, Zhang A, Ramanathan M (2006). A novel functional module detection algorithm for protein-protein interaction networks. Algorithms Mol Biol, 1, 24. https://doi.org/10.1186/1748-7188-1-24
- Jones K B, Salah Z, Del Mare S, et al (2012). miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res, 72, 1865-77. https://doi.org/10.1158/0008-5472.CAN-11-2663
- Khew-Goodall Y, Goodall GJ (2010). Myc-modulated miR-9 makes more metastases. Nat Cell Biol, 12, 209-11.
- Lau SK, Boutros PC, Pintilie M, et al (2007). Three-gene prognostic classifier for early-stage non-small-cell lung cancer. J Clin Oncol, 25, 5562-9. https://doi.org/10.1200/JCO.2007.12.0352
- Lu J, Luo H, Liu X, et al (2013). miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis, ????????.
- Ma L, Young J, Prabhala H, et al (2010). miR-9, a MYC/MYCNactivated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol, 12, 247-56.
- Ragland BD, Bell WC, Lopez RR, Siegal GP (2002). Cytogenetics and molecular biology of osteosarcoma. Lab Invest, 82, 365-73. https://doi.org/10.1038/labinvest.3780431
- Rao-Bindal K, Rao CK, Yu L, Kleinerman ES (2012). Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts. Pediatr Blood Cancer, 60, 575-9.
- Ren L, Hong S, Cassavaugh J, et al (2008). The actincytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene, 28, 792-802.
- Salinas-Souza C, De Oliveira R, Alves MT, et al (2013). The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses. Hum Pathol, 44, 2188-98. https://doi.org/10.1016/j.humpath.2013.04.013
- Smyth GK (2005). Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor. Springer.
- Smyth GK, Speed T (2003). Normalization of cDNA microarray data. Methods, 31, 265-73. https://doi.org/10.1016/S1046-2023(03)00155-5
- Sun C, Li N, Yang Z, et al (2013). mir-9 regulation of BrcA1 and Ovarian cancer Sensitivity to cisplatin and PArP inhibition. J Natl Cancer Inst, 105, 1750-8. https://doi.org/10.1093/jnci/djt302
- Tanay A, Sharan R, Kupiec M, Shamir R (2004). Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data. Proc Natl Acad Sci USA, 101, 2981-6. https://doi.org/10.1073/pnas.0308661100
- Thorsen K, Sorensen KD, Brems-Eskildsen AS, et al (2008). Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics, 7, 1214-24. https://doi.org/10.1074/mcp.M700590-MCP200
- Tsao MS, Lau S, Boutros P, et al (2011). Materials and methods for prognosing lung cancer survival. Google Patents.
- Willis RC, Hogue CW (2006). Searching, viewing, and visualizing data in the Biomolecular Interaction Network Database (BIND). Curr Protoc Bioinformatics, Chapter 8: Unit 8.9.
- Zhang B, Kirov S, Snoddy J (2005). WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res, 33, W741-8. https://doi.org/10.1093/nar/gki475
- Zhang B, Pan X, Cobb GP, Anderson TA (2007). microRNAs as oncogenes and tumor suppressors. Dev Biol, 302, 1-12. https://doi.org/10.1016/j.ydbio.2006.08.028
- Zhang H, Cai X, Wang Y, et al (2010). microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep, 24, 1363-9.
- Zhao Y, Li C, Wang M, et al (2013). Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer. PloS One, 8, e69756. https://doi.org/10.1371/journal.pone.0069756
- Zhou G, Shi X, Zhang J, et al (2013). MicroRNAs in osteosarcoma: From biological players to clinical contributors, a review. J Int Med Res, 41, 1-12. https://doi.org/10.1177/0300060513475959
피인용 문헌
- TRAIL Based Therapy: Overview of Mesenchymal Stem Cell Based Delivery and miRNA Controlled Expression of TRAIL vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6495
- Gemcitabine for the Treatment of Patients with Osteosarcoma vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7159
- Experimental Study on Residual Tumor Angiogenesis after Cryoablation vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2491
- Clinicopathologic Features and Prognosis of Osteosarcoma in Turkish Adults vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3537
- Identification of critical genes and gene interaction networks that mediate osteosarcoma metastasis to the lungs vol.10, pp.5, 2015, https://doi.org/10.3892/etm.2015.2767
- Small interfering RNA-induced silencing of galectin-3 inhibits the malignant phenotypes of osteosarcoma in vitro vol.12, pp.4, 2015, https://doi.org/10.3892/mmr.2015.4165
- Genome-wide analysis of microRNA and mRNA expression signatures in cancer vol.36, pp.10, 2015, https://doi.org/10.1038/aps.2015.67
- miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met vol.48, pp.3, 2015, https://doi.org/10.1111/cpr.12187
- Demethylation of microRNA-142 induced by demethylation agents plays a suppressive role in osteosarcoma cells pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3036
- Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma vol.38, pp.2, 2016, https://doi.org/10.3892/ijmm.2016.2657
- Molecular characterization of metastatic osteosarcoma: Differentially expressed genes, transcription factors and microRNAs vol.15, pp.5, 2017, https://doi.org/10.3892/mmr.2017.6286
- MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma vol.14, pp.2, 2017, https://doi.org/10.3892/ol.2017.6393
- Transcriptome analysis and prognosis of ALDH isoforms in human cancer vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-21123-4
- Identification of Prognostic and Predictive Osteosarcoma Biomarkers vol.7, pp.2, 2019, https://doi.org/10.3390/medsci7020028